Universe Other Assets vs Other Stockholder Equity Analysis
UPC Stock | USD 2.51 0.07 2.71% |
Universe Pharmaceuticals financial indicator trend analysis is much more than just breaking down Universe Pharmaceuticals prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Universe Pharmaceuticals is a good investment. Please check the relationship between Universe Pharmaceuticals Other Assets and its Other Stockholder Equity accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.
Other Assets vs Other Stockholder Equity
Other Assets vs Other Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Universe Pharmaceuticals Other Assets account and Other Stockholder Equity. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Universe Pharmaceuticals' Other Assets and Other Stockholder Equity is 0.95. Overlapping area represents the amount of variation of Other Assets that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Universe Pharmaceuticals, assuming nothing else is changed. The correlation between historical values of Universe Pharmaceuticals' Other Assets and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Assets of Universe Pharmaceuticals are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Other Assets i.e., Universe Pharmaceuticals' Other Assets and Other Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.95 |
Relationship Direction | Positive |
Relationship Strength | Very Strong |
Other Assets
Other Stockholder Equity
Most indicators from Universe Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Universe Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.As of May 17, 2024, Tax Provision is expected to decline to about 1.6 M. In addition to that, Selling General Administrative is expected to decline to about 1.8 M
2021 | 2022 | 2023 | 2024 (projected) | Interest Expense | 162.4K | 156.8K | 180.3K | 153.8K | Depreciation And Amortization | 621.5K | 508.8K | 457.9K | 427.6K |
Universe Pharmaceuticals fundamental ratios Correlations
Click cells to compare fundamentals
Universe Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Universe Pharmaceuticals fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 28.8M | 70.1M | 59.5M | 53.3M | 61.3M | 47.2M | |
Short Long Term Debt Total | 2.6M | 4.3M | 3.9M | 5.5M | 6.3M | 3.9M | |
Other Current Liab | 2.7M | 1.6M | 6.1M | 3.7M | 3.3M | 3.6M | |
Total Current Liabilities | 8.0M | 11.2M | 13.1M | 13.8M | 15.8M | 12.8M | |
Total Stockholder Equity | 20.8M | 58.9M | 46.4M | 39.5M | 45.5M | 34.4M | |
Net Tangible Assets | 12.2M | 20.6M | 58.8M | 46.3M | 53.2M | 32.4M | |
Property Plant And Equipment Net | 4.4M | 15.4M | 13.6M | 15.0M | 17.2M | 10.6M | |
Net Debt | (7.4M) | (3.7M) | (1.8M) | 197.2K | 226.8K | 238.1K | |
Retained Earnings | 13.7M | 25.1M | 16.3M | 10.2M | 11.7M | 13.6M | |
Accounts Payable | 2.7M | 5.3M | 3.1M | 4.6M | 5.3M | 3.8M | |
Cash | 10.1M | 8.1M | 5.7M | 5.3M | 6.1M | 7.1M | |
Non Current Assets Total | 5.5M | 19.7M | 18.0M | 16.5M | 18.9M | 13.1M | |
Other Assets | 168.1K | 186.5K | 14.1M | 12.9M | 14.9M | 15.6M | |
Cash And Short Term Investments | 10.1M | 21.8M | 18.9M | 18.5M | 21.3M | 14.4M | |
Net Receivables | 10.9M | 15.8M | 15.2M | 10.7M | 12.3M | 12.2M | |
Liabilities And Stockholders Equity | 28.8M | 70.1M | 59.5M | 53.3M | 61.3M | 47.2M | |
Inventory | 1.9M | 2.5M | 2.2M | 3.3M | 3.0M | 2.8M | |
Other Current Assets | 443.7K | 10.4M | 1.7M | 626.2K | 720.2K | 684.2K | |
Total Liab | 8.0M | 11.2M | 13.1M | 13.8M | 15.8M | 12.8M | |
Net Invested Capital | 23.4M | 63.3M | 50.4M | 45.0M | 51.8M | 38.4M | |
Long Term Investments | 735K | 744.9K | 702.9K | 685.3K | 616.8K | 572.9K | |
Property Plant And Equipment Gross | 4.4M | 15.4M | 19.3M | 21.0M | 24.2M | 12.8M | |
Short Long Term Debt | 2.6M | 4.3M | 3.9M | 5.5M | 6.3M | 3.9M | |
Total Current Assets | 23.3M | 50.5M | 41.5M | 36.8M | 42.3M | 34.1M | |
Accumulated Other Comprehensive Income | 3.3M | 4.5M | 772.8K | 26.3K | 23.6K | 22.5K | |
Net Working Capital | 15.3M | 39.3M | 28.4M | 23.1M | 26.5M | 21.3M | |
Short Term Debt | 2.6M | 4.3M | 3.9M | 5.5M | 6.3M | 3.9M | |
Intangible Assets | 174.8K | 178.5K | 157.5K | 148.6K | 133.7K | 135.3K | |
Property Plant Equipment | 4.6M | 4.4M | 4.7M | 4.3M | 3.8M | 3.7M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.C | Citigroup | |
CRM | Salesforce | |
MSFT | Microsoft |
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Universe Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Complementary Tools for Universe Stock analysis
When running Universe Pharmaceuticals' price analysis, check to measure Universe Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Universe Pharmaceuticals is operating at the current time. Most of Universe Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Universe Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Universe Pharmaceuticals' price. Additionally, you may evaluate how the addition of Universe Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Universe Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.82) | Earnings Share (1.70) | Revenue Per Share 8.913 | Quarterly Revenue Growth (0.13) | Return On Assets (0.04) |
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.